BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22528930)

  • 1. Medullary carcinoma of the breast: MRI findings.
    Jeong SJ; Lim HS; Lee JS; Park MH; Yoon JH; Park JG; Kang HK
    AJR Am J Roentgenol; 2012 May; 198(5):W482-7. PubMed ID: 22528930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of medullary carcinoma of the breast.
    Tominaga J; Hama H; Kimura N; Takahashi S
    Eur J Radiol; 2009 Jun; 70(3):525-9. PubMed ID: 18353587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging features of pure mucinous carcinoma of the breast.
    Okafuji T; Yabuuchi H; Sakai S; Soeda H; Matsuo Y; Inoue T; Hatakenaka M; Takahashi N; Kuroki S; Tokunaga E; Honda H
    Eur J Radiol; 2006 Dec; 60(3):405-13. PubMed ID: 16963218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors.
    Matsubayashi R; Matsuo Y; Edakuni G; Satoh T; Tokunaga O; Kudo S
    Radiology; 2000 Dec; 217(3):841-8. PubMed ID: 11110952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters.
    Tozaki M; Igarashi T; Matsushima S; Fukuda K
    Radiat Med; 2005 Feb; 23(1):43-50. PubMed ID: 15786751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast carcinomas with strong high-signal intensity on T2-weighted MR images: pathological characteristics and differential diagnosis.
    Yuen S; Uematsu T; Kasami M; Tanaka K; Kimura K; Sanuki J; Uchida Y; Furukawa H
    J Magn Reson Imaging; 2007 Mar; 25(3):502-10. PubMed ID: 17326093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
    Gokalp G; Topal U; Yildirim N; Tolunay S
    Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous carcinoma of the breast: MRI features of pure and mixed forms with histopathologic correlation.
    Monzawa S; Yokokawa M; Sakuma T; Takao S; Hirokaga K; Hanioka K; Adachi S
    AJR Am J Roentgenol; 2009 Mar; 192(3):W125-31. PubMed ID: 19234240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can MR Imaging contribute in characterizing well-circumscribed breast carcinomas?
    Yoo JL; Woo OH; Kim YK; Cho KR; Yong HS; Seo BK; Kim A; Kang EY
    Radiographics; 2010 Oct; 30(6):1689-702. PubMed ID: 21071383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced high-resolution MRI of invasive breast cancer: correlation with histopathologic subtypes.
    Kitagawa K; Sakuma H; Ishida N; Hirano T; Ishihara A; Takeda K
    AJR Am J Roentgenol; 2004 Dec; 183(6):1805-9. PubMed ID: 15547233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI features of stromal fibrosis of the breast with histopathologic correlation.
    Lee SJ; Mahoney MC; Khan S
    AJR Am J Roentgenol; 2011 Sep; 197(3):755-62. PubMed ID: 21862821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A wide variety of dynamic contrast-enhanced MR appearances of breast cancer: pathologic correlation study.
    Onishi M; Furukawa A; Takahashi M; Murata K
    Eur J Radiol; 2008 Feb; 65(2):286-92. PubMed ID: 17683886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of imaging and pathology features of mucinous carcinoma of the breast.
    Zhang L; Jia N; Han L; Yang L; Xu W; Chen W
    Clin Breast Cancer; 2015 Apr; 15(2):e147-54. PubMed ID: 25523373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
    Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
    J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI study of solitary fibrous tumor in the orbit.
    Yang BT; Wang YZ; Dong JY; Wang XY; Wang ZC
    AJR Am J Roentgenol; 2012 Oct; 199(4):W506-11. PubMed ID: 22997401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.